Baseline and changes in inflammatory parameters for patients with <scp><i>EGFR</i></scp>‐mutated <scp>NSCLC</scp> treated with afatinib
Our study presented the NLR, MLR, and PLR as prognostic factors for patients with NSCLC treated with afatinib. Further investigation into these markers representing the tumor microenvironment and their association with cancer status is crucial for evaluating prognosis and clinical outcomes in patients with NSCLC.
Authors
- Chih‐Hsi S. Kuo (ORCID: https://orcid.org/0000-0003-3309-937X)
- Ching‐Fu Chang (ORCID: https://orcid.org/0000-0001-5219-6357)
- Cheng‐Ta Yang (ORCID: https://orcid.org/0000-0003-1846-1027)
- Ping‐Chih Hsu (ORCID: https://orcid.org/0000-0003-0173-7509)
- John Wen‐Cheng Chang (ORCID: https://orcid.org/0000-0001-8373-5691)
- How‐Wen Ko (ORCID: https://orcid.org/0000-0002-6415-2965)
- Chen‐Yang Huang (ORCID: https://orcid.org/0000-0002-6767-0389)
- Zi‐Ting Chang
- Chen‐Te Wu
- Chiao‐En Wu (ORCID: https://orcid.org/0000-0002-1900-2984)
Institutions
- Chang Gung University (TW)
- Linkou Chang Gung Memorial Hospital (TW)
Publication Details
- Journal
- Thoracic Cancer
- Published
- 2025-04-17
- DOI
- https://doi.org/10.1111/1759-7714.15338
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Chang Gung Memorial Hospital, Linkou
- National Science and Technology Council